DNDi and Cipla advance development of pediatric 4-in-1 ARVs to fulfill new WHO guidelines

... guidelines , Dr Jaideep A Gogtay, Chief Medical Officer of Cipla, said, 'Cipla reinforces its commitment towards HIV/AIDS and will continue to develop novel and child-friendly formulations to ensure wider access of ARV drugs to HIV-infected ...

http://medicalxpress.com/news/2013-06-dndi-cipla-advance-pediatric-in-.html